Sai Life Sciences IPO is set to debut on the stock exchanges today, December 18, 2024, with trading scheduled to begin at 10:00 AM in a special pre-open session on the BSE and NSE.
Sai Life Sciences IPO Details:
- IPO Subscription: Oversubscribed 10.27 times
- Issue Price: ₹549 per share
- IPO Listing Date: December 18, 2024
- Stock Exchanges: BSE and NSE
Sai Life Sciences IPO GMP Today:
The Grey Market Premium (GMP) for Sai Life Sciences IPO is currently at ₹72 per share. This indicates a potential listing price of ₹621 per share, suggesting an approximate 13% gain over the issue price.
Company Overview:
Sai Life Sciences specializes in research, development, and manufacturing of small-molecule novel chemical entities for global pharmaceutical and biotech companies. With a strong presence across the US, UK, Europe, and Japan, the company’s robust financial performance and profitability have driven investor interest.
Key Takeaways:
- Estimated Listing Price: ₹621 (11-13% premium)
- GMP Trend: Positive sentiment in the grey market
- Subscription: 10.27 times, indicating decent demand from investors
The listing of Sai Life Sciences today is expected to be positive, delivering moderate gains for IPO investors despite concerns around higher valuations.
